On the contrary, blocking PK2 activity via specific PKR antagonists alleviates the neuropathy-induced pain and reduces the neuroinflammatory state in the sensory nerves, DRG, and spinal cord [155,156,157]. This evidence concerns the gene PROK2 and neuropathy.